# Medeliver Intracranial Drug Coated Balloon Catheter for Symptomatic Intracranial Atherosclerotic Stenosis

> **NCT07542938** · NA · NOT_YET_RECRUITING · sponsor: **Xuanwu Hospital, Beijing** · enrollment: 264 (estimated)

## Conditions studied

- Symptomatic Intracranial Atherosclerotic Stenosis

## Interventions

- **DEVICE:** Intracranial Drug-Coated Balloon Catheter (Medeliver®)
- **DEVICE:** Intracranial Balloon Dilatation Catheter (Diveroad®)

## Key facts

- **NCT ID:** NCT07542938
- **Lead sponsor:** Xuanwu Hospital, Beijing
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-15
- **Primary completion:** 2026-11-30
- **Final completion:** 2027-11-30
- **Target enrollment:** 264 (ESTIMATED)
- **Last updated:** 2026-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07542938

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07542938, "Medeliver Intracranial Drug Coated Balloon Catheter for Symptomatic Intracranial Atherosclerotic Stenosis". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT07542938. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*